Sanofi To Take $118.5-Million Charge for Dengue Vaccine
By

By
Sanofi plans to take a $118.5-million charge related to Dengvaxia, the company’s vaccine for dengue fever, following an analysis of long-term clinical trial data, which found differences in vaccine performance…

Shire Appoints Head of R&D and CSO
By

By
Shire has appointed Andreas Busch, PhD, as executive vice president, head of research and development (R&D), chief scientific officer, and a member of the company’s Executive Committee beginning in January…

Gritstone Oncology Opens Pharma Mfg Facility
By

By
Gritstone Oncology, an Emeryville, California-based personalized cancer immunotherapy company, has opened a new 43,000-square-foot manufacturing facility in Pleasanton, California. The fully operational biomanufacturing facility, which includes multiple cleanrooms, each to…

Orchard Therapeutics Expands Gene Therapy Mfg
By

By
Orchard Therapeutics, a Foster City, California-based clinical-stage biotechnology company, has opened a second facility for technical operations that support development and validation of processes and controls for the manufacture of…

Piramal Acquires Brands for Consumer Products Business
By

By
Piramal Enterprises, a Mumbai, India-based business conglomerate that includes pharmaceuticals, reports that its Consumer Products Division has agreed to acquire brands from Shreya Lifescience, a Mumbai, India-based biopharmaceutical company. This…

FDA Issues Final Guidance on 3D Printing of Medical Products
By

By
The US Food and Drug Administration (FDA) has issued final guidance, Technical Considerations for Additive Manufactured Medical Devices, to clarify what the FDA recommends manufacturers include on submissions for 3D-printed…

Bayer Combines Pharma Research and Development Unit
By

By
Bayer has decided to combine its pharmaceutical research and development activities under one leadership. The unit will combine all research and development activities for the therapeutic areas of cardiology, gynecology,…

Takeda To Move Tokyo HQ
By

By
Takeda Pharmaceutical Company has signed an agreement with Takashimaya Company to sell the Tokyo Takeda Building, the company’s current Tokyo headquarters, and the Takeda Shin-Edobashi Building. Takeda is globally headquartered…

Astellas To Acquire Mitobridge in a Deal Worth Up to $450 Million
By

By
Astellas Pharma has agreed to acquire Mitobridge, a Cambridge, Massachusetts-headquartered company developing small-molecule therapeutics that improve mitochondrial functions, for up to $450 million under amended terms of their October 2013…

Pfizer in Pact to Develop Antifungal Drug in Asia-Pacific Region
By

By
Pfizer and Basilea Pharmaceutica, a Swiss biopharmaceutical company specializing in anti-infective and oncological medicines, have signed an agreement to grant Pfizer the exclusive development and commercialization rights for Basilea’s Cresemba…